titrating tirzepatide Dosing Tirzepatide Dosage & Titration: Complete

In the head-to-head SURMOUNT-5 trial (NEJM 2025), tirzepatide produced 20.2% weight loss vs 13.7% for semaglutide at 72 weeks

All plans include medical evaluation, medication, supplies, free shipping, and ongoing provider access

Always replace the cap between uses to protect the medicine from light, and discard a pen 30 days after first use

As a result, for many, Mounjaro can be a supportive tool for significant weight loss: In the SURMOUNT-3 phase 3 clinical trial on tirzepatide (Mounjaro) for obesity and overweight, participants who took the drug and made lifestyle changes for 72 weeks, following 12 weeks of intensive lifestyle changes, lost on average 24.3% to 26.6% of their body weight

The FDAs formal guidance against compounded semaglutide projected to eliminate USD 3.6 billion in compounding pharmacy and telehealth revenue in 20252026 creates disruption risk for approximately 1.5 million patients receiving compounded GLP-1 outside branded channels

Ask about periodic labs and imaging when clinically indicated